郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation.

期刊：Biomolecules发表年份：2021作者：Rosa Maria Vitale; Fabio Arturo Iannotti; Aniello Schiano Moriello; Lea Tunisi; Fabiana Piscitelli; Ranjev Savopoulos; Luigia Cristino; Luciano De Petrocellis; Pietro Amodeo; Roy Gray; Vincenzo Di Marzo
阅读更多 →

药效评价Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting.

期刊：International journal of molecular sciences发表年份：2021作者：Suman Rao; Benoît Thibault; Lisa Peyrard; Anne-Laure Larroque-Lombard; Martin Rupp; Cédric Thauvin; Bertrand J Jean-Claude
阅读更多 →

药效评价From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.

期刊：Cell发表年份：2021作者：Alastair J H Brown; Sophie J Bradley; Fiona H Marshall; Giles A Brown; Kirstie A Bennett; Jason Brown; Julie E Cansfield; David M Cross; Chris de Graaf; Brian D Hudson; Louis Dwomoh; João M Dias; James C Errey; Edward Hurrell; Jan Liptrot; Giulio Mat
阅读更多 →

药效评价Recombinant Human HPS Protects Mice and Nonhuman Primates from Acute Liver Injury.

期刊：International journal of molecular sciences发表年份：2021作者：Yang Yang; Huali Zhai; Yue Wan; Xiaofang Wang; Hui Chen; Lihou Dong; Taoyun Liu; Guifang Dou; Chutse Wu; Miao Yu
阅读更多 →